2B BlackBio

BlackBio develops and markets new solutions for personalized medicine based on genetics, genomics and proteomics (one international patent and five patents pending). BlackBio’s mission is to make Personalized Medicine a reality, translating genomic and proteomic advances to the Company, an become an international benchmark in the personalized medicine market, as a generator of new technologies and products that help pharmaceutical companies and physicians to improve health and quality of life of patients. Also, to help citizens to take direct responsibility for and to make informed decisions about their own health.

Strategy

•    Application of new, proprietary, state-of-art technologies for the detection of genomic and proteomic biomarkers
•    International scope
•    Commercialisation through the web site with access restricted to final customers
•    Development for third parties
•    Focus in Oncology, Wellness, Cardiovascular, Allergy, Pharmacogenomics and Microbiology
•    Diversified tools: micro sequencing, protein microarrays, real time PCR